Legal & General Group’s Core Scientific CORZ Stock Holding History

Legal & General Group’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.29M	Sell	206,626 -292	-0.1%	-$6.88K	﹤0.01%	1552
2026 Q1	$3.1M	Sell	206,918 -51,629	-20%	-$881K	﹤0.01%	1731
2025 Q4	$3.76M	Sell	258,547 -3,136	-1%	-$54.7K	﹤0.01%	1718
2025 Q3	$4.69M	Buy	261,683 +480	+0.2%	+$7.04K	﹤0.01%	1618
2025 Q2	$4.46M	Buy	261,203 +40,774	+18%	+$408K	﹤0.01%	1602
2025 Q1	$1.6M	Buy	220,429 +26,061	+13%	+$297K	﹤0.01%	2012
2024 Q4	$2.73M	Buy	194,368 +58,810	+43%	+$869K	﹤0.01%	1850
2024 Q3	$1.61M	Buy	135,558 +112,361	+484%	+$1.16M	﹤0.01%	2062
2024 Q2	$216K	Buy	+23,197	New	+$118K	﹤0.01%	2655

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Legal & General Group's CORZ Position: Q2 2026 in Review

Legal & General Group reduced its Core Scientific (CORZ) stake by 0.14% in Q2 2026, selling an estimated $6.88K and leaving 206,626 shares worth $5.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

Legal & General Group first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Legal & General Group held 206,626 shares of Core Scientific worth $5.29M as of Q2 2026.
Legal & General Group sold 292 Core Scientific shares in Q2 2026, an estimated $6.88K.
Core Scientific made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1552 holding.
Legal & General Group first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.